Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daphne A Haas-Kogan, M.D.


This page shows the publications co-authored by Daphne Haas-Kogan and Sharmistha Pal.
Connection Strength

  1. Dual HDAC and PI3K Inhibition Abrogates NF?B- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas. Cancer Res. 2018 07 15; 78(14):4007-4021.
    View in: PubMed
    Score: 0.783
  2. Harnessing Lactate Metabolism for Radiosensitization. Front Oncol. 2021; 11:672339.
    View in: PubMed
    Score: 0.061
  3. Lipidome-based Targeting of STAT3-driven Breast Cancer Cells Using Poly-l-glutamic Acid-coated Layer-by-Layer Nanoparticles. Mol Cancer Ther. 2021 04; 20(4):726-738.
    View in: PubMed
    Score: 0.059
  4. Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312). Clin Cancer Res. 2020 03 15; 26(6):1213-1219.
    View in: PubMed
    Score: 0.055
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.